日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Opinion Line

No tariffs on targeted cancer drugs will reduce the price pain for patients

China Daily | Updated: 2018-03-22 07:07
Share
Share - WeChat

Premier Li Keqiang promises zero tariff rates for targeted cancer drugs at a news conference after the two sessions in Beijing on Tuesday. Thepaper.cn comments:

It is estimated more than 2 million people die of cancer in China each year. If there are zero tariffs, the retail price of the imported lifesaving drugs used in targeted cancer therapies will drop markedly. Their high prices have resulted in a large number of cancer patients exhausting their savings to extend their lives for a short time.

Some imported targeted cancer therapies can cost a patient as much as 10,000 yuan ($1,579) a dose as they are not covered by the medical insurance system. The high prices mean many patients have to give up their treatment.

More and more patients have turned to buying medicines from India through various channels as the prices are much lower, or to generic drugs that are lower in both price and efficiency. They then take the medicines at home without professional instruction and monitoring, further risking their health.

Aside from the tariffs, the high retail price of imported drugs in China is also pushed up by agents' fees, value-added tax, and high basic prices, which stem from the super-national treatment that some foreign medicines have been enjoying in the drug procurement of public hospitals, even if some of their patent protections have expired.

The pledge to end the tariffs on targeted cancer therapies indicates that the government recognizes they are special goods concerning people's welfare. But even without the tariffs, there still remains considerable room to squeeze the profit links between customs and patients to further bring down the prices of the drugs.

That the government has to open doors to imported drugs to save people's lives should also ring alarm bells for domestic pharmaceutical companies, especially the State-owned ones, as they have no reasons to sit idle, and are obliged to strengthen their research into these badly needed medicines and try their best to acquire the ability of producing them as early as possible.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 久久久成人免费视频 | 欧美www. | 色网站视频 | 黄色大片免费观看 | 国产日韩欧美综合 | 一级片免费观看 | 欧美精品四区 | 色老大影院 | 亚洲另类天堂 | 日本天天色 | 日本高清www免费视频 | 成人国产精品久久 | 毛片aaa| 日少妇视频 | 97久久国产| 日韩精品一区二区三区在线播放 | 精品美女一区二区 | 欧美日韩成人精品 | 91视频日本| 国产第一页在线 | 中文字幕不卡在线观看 | 91久热| 伊人免费视频 | av网站免费在线播放 | 久久综合免费视频 | 超碰520 | 色婷婷在线视频 | 亚洲激情文学 | 在线播放a| 手机看片久久久 | 欧美网站在线观看 | 日韩av在线播放观看 | 奇米影视久久 | 肉视频在线观看免费 | 日韩免费视频网站 | 黄色免费看 | 黄色片毛片 | 久久国产精品久久精品国产 | 成年人在线观看网站 | 日本黄色免费视频 | 日本一级片在线播放 |